Clinical and cost-effectiveness of ACE inhibitors in patients with arterial hypertension and coronary heart disease
Abstract
Aim. To compare clinical and cost-effectiveness of ACE inhibitors in patients with arterial hypertension (AH) and coronary heart disease (CHD), aiming to guide the appropriate medication selection process.
Material and methods. The study included 60 patients, receiving standard combined pharmaceutical treatment, plus perindopril, or moexipril, or fosinopril (n=20 in each group). At Day 7, all patients were administered ramipril.
Results. Clinical effectiveness of fosinopril, moexipril, perindopril and ramipril was similar: in all groups, significant blood pressure reduction was achieved by Day 6 and sustained till Day 38 of ramipril therapy. All ACE inhibitors were well-tolerated. Maximal cost-effectiveness ("minimal cost" method) was observed for ramipril.
Conclusion. Assessing clinical and cost-effectiveness of various medications from one pharmacological group could be used for developing pharmaceutical therapy standards aimed to guide the medication selection process in individual patients.
About the Authors
O. Yu. KorennovaRussian Federation
A. V. Petrenko
Russian Federation
M. A. Petrenko
Russian Federation
E. V. Kurt-Kovalenko
Russian Federation
E. A. Turusheva
Russian Federation
T. A. Natsarenus
Russian Federation
S. V. Alekseeva
Russian Federation
L. G. Mashinskaya
Russian Federation
M. I. Shupina
Russian Federation
E. A. Osipova
Russian Federation
References
1. Остроумова О.Д., Мамаев В.И. Фармакоэкономические аспекты лечения артериальной гипертонии. Артер гиперт 2002; 8(6): 193-9.
2. Белоусов Ю.Б., Тхостова Э.Б. Классы гипотензивных препаратов: стратегия и тактика выбора первого препарата. Сердце 2002; 5(5): 220-9.
3. Воробьев П.А., Аксентьева М.В., Юрьев А.С., Сура М.В. Клинико-экономический анализ. Ньюдиамед 2004: 404 с.
4. Приложение к Приказу Федеральной службы по надзору в сфере здравоохранения и социального развития от 02.10.2006 г. № 2240-Пр/06.
5. Петри А. Наглядная статистика в медицине. Пер. с англ. В.П. Леонова. А. Петри, К. Сэбин. Москва "ГЭОТАР МЕД" 2003; 144 с.
Review
For citations:
Korennova O.Yu., Petrenko A.V., Petrenko M.A., Kurt-Kovalenko E.V., Turusheva E.A., Natsarenus T.A., Alekseeva S.V., Mashinskaya L.G., Shupina M.I., Osipova E.A. Clinical and cost-effectiveness of ACE inhibitors in patients with arterial hypertension and coronary heart disease. Cardiovascular Therapy and Prevention. 2008;7(4):41-44. (In Russ.)